Glass House Brands Inc. Subordi (GLAS) Stock Price & How to Invest

Glass House Brands is a vertically integrated cannabis company headquartered in Long Beach, California, that reports across three segments: Wholesale Biomass (selling bulk cannabis flower and trim), Retail (its own dispensaries), and Cannabis-Related Consumer Packaged Goods (its branded products). Its defining asset is massive greenhouse cultivation capacity, anchored by a large SoCal Farm, that lets it grow cannabis at a low cost per pound relative to indoor growers. The strategy is scale and cost leadership: produce enormous volumes of biomass cheaply, sell into the California wholesale market, and layer higher-margin brands and retail on top. Wholesale biomass has recently made up the majority of revenue, and the company has been expanding planted acreage and building out additional greenhouse capacity.

The challenge is that California wholesale cannabis prices have been deeply depressed by oversupply, which squeezes the very market Glass House sells into. In Q1 2026 the company reported revenue of roughly $40.5 million, down from about $44.8 million a year earlier, with gross margin compressing to around 25% (versus roughly 45% in the prior-year quarter) as average selling prices fell to about $171 per pound and production costs rose. Losses deepened. For full-year 2026 the company guided to roughly $235 to $245 million in net revenue and about 1,000,000 pounds of biomass production, while trimming profitability expectations. Management is leaning on potential federal catalysts (rescheduling cannabis to Schedule III, and international export opportunities such as its first hemp and CBD biomass sale to Europe in 2026) and has discussed strategic moves around its retail business. All specific figures are approximate and tied to reporting dates; verify current numbers before acting.

The dominant risk is California wholesale cannabis pricing, which has been deeply depressed by oversupply and drove average selling prices and gross margin sharply lower, keeping the company unprofitable. Glass House is highly exposed to that single market, so a prolonged price slump directly threatens its economics. Cannabis remains federally illegal in the US, which blocks interstate commerce, imposes the heavy 280E tax on operators, limits banking access, and keeps many institutional investors on the sidelines; the hoped-for rescheduling to Schedule III is uncertain in both timing and final form. Execution risk is real as the company scales greenhouse capacity while cutting costs, and any shortfall in production, yields, or selling prices flows straight to the bottom line. The stock is small, volatile, and event-driven, and dilution or additional financing to fund growth is a recurring possibility. International and hemp opportunities are early and unproven at scale.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Glass House Brands Inc. Subordi's investor relations page or your broker.

• Revenue trend: Roughly $40.5 million in Q1 2026, down from about $44.8 million a year earlier; full-year 2026 guidance around $235 to $245 million. Wholesale biomass has been the majority of revenue. Approximate; verify live.
• Profitability: Unprofitable. Gross margin compressed to around 25% in Q1 2026 (versus roughly 45% a year earlier) and net losses deepened as selling prices fell and costs rose. Approximate; verify live.
• Unit economics: Average selling price around $171 per pound in Q1 2026, down from roughly $193 a year earlier, reflecting weak California wholesale pricing. Biomass production guided near 1,000,000 pounds for 2026. Approximate; verify live.
• Balance sheet: A scaling grower funding greenhouse expansion while losing money, so cash generation, debt, and potential dilution are worth watching closely. Verify current figures.
• Market cap tier: Small-cap cannabis stock; high volatility and event-driven trading are typical. Uplisted to the NYSE under GLAS on June 30, 2026. Approximate; verify live.
• Valuation note: Trades largely on cannabis-industry sentiment and federal catalysts rather than current earnings, since the company is not yet profitable. Multiples on depressed or negative earnings are hard to interpret. Verify live.

These are qualitative, approximate framings tied to the asOf date, not precise live figures; confirm current numbers before acting. Because Glass House is unprofitable and its results hinge on volatile California wholesale prices and uncertain federal policy, traditional earnings multiples say little. What matters most is the direction of selling prices, production volume, cost per pound, the mix shift toward retail and brands, and any movement on rescheduling. This is a speculative, catalyst-driven cannabis stock rather than a value-of-current-earnings play.

There are three common ways to get GLAS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so GLAS sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where GLAS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

Glass House is a bet on being the lowest-cost, largest-scale cannabis greenhouse grower in California, with upside tied to volume growth, brand and retail expansion, and federal catalysts like Schedule III. The near-term reality is falling wholesale prices, compressed margins, and ongoing losses, so it is a high-risk, event-driven cannabis stock.